CFLAR and central nervous system cancer: For example, a pre-treatment using cisplatin has been reported to down-regulate FADD-like IL-1β-converting enzyme (c-FLIP) activity, which is an anti- apoptotic protein, leading to an increase in DR5 receptor expression in glioma-derived CSCs [64].